Grey Wolf Animal Health Corp. (TSXV:WOLF)

Canada flag Canada · Delayed Price · Currency is CAD
1.650
0.00 (0.00%)
At close: Apr 28, 2026
83.33%
Market Cap 56.42M
Revenue (ttm) 35.76M
Net Income (ttm) 1.66M
Shares Out 34.19M
EPS (ttm) 0.05
PE Ratio 34.05
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,200
Average Volume 36,817
Open 1.650
Previous Close 1.650
Day's Range 1.620 - 1.650
52-Week Range 0.900 - 1.760
Beta 0.38
RSI 62.18
Earnings Date May 1, 2026

About Grey Wolf Animal Health

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under t... [Read more]

CEO Angela Cechetto
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol WOLF
Full Company Profile

Financial Performance

In 2025, Grey Wolf Animal Health's revenue was 35.76 million, an increase of 33.30% compared to the previous year's 26.83 million. Earnings were 1.66 million, an increase of 135.11%.

Financial Statements

News

There is no news available yet.